The overall goal of the proposed research is to determine the mechanisms that cause impaired relaxation and Ca2+ handling in left ventricular hypertrophy (LVH) and to develop effective therapies to reverse these abnormalities. The applicant addresses three major problems. First, the mechanisms that cause slowing of relaxation, an important element of cardiac dysfunction in LVH, remain uncertain. Slowing of the decline of free cytosolic [Ca2+] ([Ca2+]c) has been reported, suggesting this may be a factor. But there are little data showing a close relationship between relaxation and [Ca2+]c decline that would support causality. Furthermore, [Ca2+]c does not directly indicate the extent to which the contractile proteins are activated by Ca2+. Second, although abnormal activity and content of SR Ca2+-ATPase have been implicated in slowing [Ca2+]c decline in LVH, a close link between [Ca2+]c decline and SR Ca2+-ATPase has not been established. Third, currently available therapies for cardiac dysfunction in LVH are not effective. Preliminary data suggest that thyroid hormone reverses slowed relaxation and [Ca2+]c decline even though treatment was started after pathological LVH was established, and despite continued pressure-overload. To address these issues, three major hypothesis will be tested: 1. Slowing of myocardial relaxation is primarily caused by slowing of the rate of [Ca2+]c decline. 2. Slowing of [Ca2+]c decline is caused by abnormal function and/or levels of SR Ca2+-ATPase. 3. Thyroid hormone accelerates relaxation and [Ca2+]c decline in pathological LVH. Isovolumic hearts (rat) will be used to establish a link between [Ca2+]c (indo-1 fluorescence) and relaxation in LVH (pressure-overload). Muscle strips will be used to determine whether slowing of Ca2+-activation is the fundamental mechanism that slows relaxation in LVH. SR Ca2+ uptake and levels of SR Ca2+-ATPase, and its regulatory protein, phospholamban, will be assessed using myocytes (Western blots).

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL054890-03
Application #
2872927
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Project Start
1997-02-01
Project End
2002-01-31
Budget Start
1999-03-08
Budget End
2000-01-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Joho, Shuji; Ishizaka, Shinji; Sievers, Richard et al. (2007) Left ventricular pressure-volume relationship in conscious mice. Am J Physiol Heart Circ Physiol 292:H369-77
Ishizaka, Shinji; Sievers, Richard E; Zhu, Bo-Qing et al. (2004) New technique for measurement of left ventricular pressure in conscious mice. Am J Physiol Heart Circ Physiol 286:H1208-15
Turnbull, Lynne; McCloskey, Diana T; O'Connell, Timothy D et al. (2003) Alpha 1-adrenergic receptor responses in alpha 1AB-AR knockout mouse hearts suggest the presence of alpha 1D-AR. Am J Physiol Heart Circ Physiol 284:H1104-9
McCloskey, Diana T; Turnbull, Lynne; Swigart, Philip et al. (2003) Abnormal myocardial contraction in alpha(1A)- and alpha(1B)-adrenoceptor double-knockout mice. J Mol Cell Cardiol 35:1207-16
McLean, B Gail; Lee, Katherine S; Simpson, Paul C et al. (2003) Basal and alpha1-adrenergic-induced activity of minimal rat betaMHC promoters in cardiac myocytes requires multiple TEF-1 but not NFAT binding sites. J Mol Cell Cardiol 35:461-71
McCloskey, Diana T; Rokosh, D Gregg; O'Connell, Timothy D et al. (2002) Alpha(1)-adrenoceptor subtypes mediate negative inotropy in myocardium from alpha(1A/C)-knockout and wild type mice. J Mol Cell Cardiol 34:1007-17
Baker, A J; Redfern, C H; Harwood, M D et al. (2001) Abnormal contraction caused by expression of G(i)-coupled receptor in transgenic model of dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 280:H1653-9
Nakamura, A; Rokosh, D G; Paccanaro, M et al. (2001) LV systolic performance improves with development of hypertrophy after transverse aortic constriction in mice. Am J Physiol Heart Circ Physiol 281:H1104-12
Figueredo, V M; Diamond, I; Zhou, H Z et al. (1999) Chronic dipyridamole therapy produces sustained protection against cardiac ischemia-reperfusion injury. Am J Physiol 277:H2091-7
Halow, J M; Figueredo, V M; Shames, D M et al. (1999) Role of slowed Ca(2+) transient decline in slowed relaxation during myocardial ischemia. J Mol Cell Cardiol 31:1739-48

Showing the most recent 10 out of 13 publications